pital

Welcome to the 29th Annual Enterprise Awards.

Our region's most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology will be taking place May 24th, 2022. Save the date - much more info to come.

NAVIGATION

CELEBRATE OUR INNOVATORS!

The 2021 Enterprise Awards will be a two-night, hybrid event featuring an in-person celebration on 6/29 and an online broadcast of the Enterprise Awards ceremony on 6/30, presented by Fairmount Partners and KPMG.

Event Pricing

PACT Member $75
Non-Member $200
Investors FREE for QUALIFIED Investors
Entrepreneur Program $100
Gala Reception $299

Registrations will only be accepted by website, post-mail, or email via cjarvisj@philadelphiapact.com. No registration will be taken over the phone, and full payment must accompany registration.

June 29th: In-Person, 6 to 9 PM

Join our nominees and VIP guests at this outdoor, tented event on the Tavola Patio at Springfield Country Club from 6:00 to 9:00 pm. Enjoy al fresco cocktails and tasting plates as you reconnect with colleagues and meet our 2021 honorees – plus a special in-person recognition of this year’s Legend Award Honoree for lifetime achievement, Josh Kopelman.

June 30th: Virtual Ceremony Broadcast, 4:30 to 5:45 PM

The 28th Annual Enterprise Awards Ceremony Broadcast will take place from 4:30pm – 5:45pm, where we will announce all of our winners.

IMG_5915

Award Criteria

To View the Enterprise Awards Applications, please click on each award heading below.

Nomination Form »

The Deadline for Nominations is Friday, November 19th

Title Sponsor: Fairmount Partners

Judging Partner: KPMG LLP

Technology Emerging

Sponsor: Fox Rothschild LLP

Criteria:

  • Company must have been in operation before January 1, 2018. Revenues must be less than $50 million, except in the most recent fiscal year.

Key Considerations:

  • Product or service innovation, including proprietary technology or other advantage.
  • Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
  • Strength of management team including ability to raise capital.
  • Profitability or demonstrated ability to achieve profitability (e.g. strategy to achieve break even, the ability to realize high gross margins, etc.), and decisions that led to corporate collaborations or license deals.

Technology Startup

Sponsors: Troutman Pepper

Criteria:

  • Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

  • Product or service innovation including market need or assessment.
  • Potential for significant growth.
  • The management team and its ability and record of achieving success.
  • A demonstration of success such as significant milestones, raising capital, and revenue.

Technology CEO

Sponsor: Cozen O’Connor

Criteria:

  • Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talent.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community and/or industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the tech industry in the region.

Investment Deal

Sponsor: EPAM and Baker Tilly

Criteria:

  • Deal must have been fully executed between January 1, 2021 and December 31, 2021.
  • Events that qualify for this category include Exit Transaction (e.g. IPO), Capital Raising Transaction (e.g. financing: debt, mezzanine, equity; recap), Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

Entries must include a Business and Transaction Narrative/Summary.

Life Sciences & Healthcare Startup

Sponsor: Ben Franklin Technology Partners

Criteria:

  • Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

  • Discuss product innovation including market need/assessment and potential for significant growth.
  • Discuss the management team and its ability and record of achieving success.
  • Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
  • Describe the R&D investment strategy.
  • What did the company do to overcome challenges in financing, development or commercialization?

Life Sciences & Healthcare Emerging

Sponsor: RSM US LLP and SAP

Criteria:

  • Company must have been in operation before January 1, 2018. Must have sales, grants, or licensing fees. The Company should have no more than 3 years of operating results since its founding.

Key Considerations:

  • Describe product, including proprietary applications or other advantage.
  • What animal or OUS (outside of the United States) clinical work has been done to prove the technology?
  • Describe the impact on the clinical problem this technology is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
  • Address the strength of the management team including ability to raise capital.
  • Profitability or demonstrated ability to achieve profitability (e.g., strategy to achieve break even, ability to realize high gross margins, etc.) or decisions that led to corporate collaborations or license deals.

Life Sciences & Healthcare Company

Sponsor: Coming Soon

Criteria:

  • Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medical
    devices/instrumentation, therapeutics and diagnostics.

Key Considerations:

  • Company should demonstrate the impact of a proprietary product to the patient and/or clinician or research and development of an innovative product and its potential impact on the market.
  • Company should demonstrate its ability to raise capital; generate revenue; and commercialization and/or strategy to enter into substantive strategic alliances.
  • Company should also demonstrate its development strategy and clinical pathway to development.
  • Describe any significant events, e.g. product discovery, drug registration, an exit, an increase in sales etc. that occurred in 2021.
  • What did the company do to overcome challenges in financing, development, or commercialization?

Technology Company

Sponsor: Comcast Business

Criteria:

  • Company with more than $50 million in revenues in the most recently completed fiscal year.

Key Considerations:

  • Leadership and product and/or service innovation in an industry or market.
  • Significant company milestones including financial accomplishments.
  • Community and industry involvement.

Life Sciences & Healthcare CEO

Sponsors: EY and Morgan Lewis

Criteria:

  • Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

  • Describe CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community/industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.

Healthcare Innovator

Sponsor: Independence Blue Cross

Criteria:

  • The nominee can be a company, researcher, investor, or individual providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.

Key Considerations:

  • The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth.
  • The nominee should be able to demonstrate return on investment or clinical impact of its solution.
  • The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.
  • The nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.

 

Legend Award (Lifetime Achievement)

Sponsor: Cigniti Technologies

The Legend Award for Lifetime Achievement is presented to an individual who has forwarded technology and sciences in the region through leadership and exemplary work. The Legend recipient must have a strong connection to the community, a history of personal accomplishments and a track record of success.

Judges

Technology Judges

Jared Blitzstein

Director, Software Engineering
Boomi

Greg Doran

Chief Financial Officer
Frontline Education

Sean Dowling

Partner
Osage Partners

Shintaro Kaido

Vice Provost & Chief Innovation Officer, Drexel Applied Innovation
Drexel University

Brian Kim

Partner
NewSpring Capital

Aimee Senour

Vice President, Business Development
Cigniti Technologies

Brian McCabe

Senior Director, Technology Finance
BridgeBank

Dan Klein

Managing Director
Slalom

Nihad Rahman

Managing Director
InstaMed, a JP Morgan Company

Nassar Nizami

CIO
Jefferson University/Einstein

Debbie O’Brien

Senior Vice President, Market Manager
Bank of America

Pooja Ojala

Vice President, Strategy
Veeva

Daphne Thomas

Chief Operating Officer
iPipeline

April Walker

Senior Director
US Microsoft Technology Centers

Life Sciences & Healthcare Judges

Kevin Brophy

Life Sciences Industry Principal
SAP

Carol Burnes

CEO
Cagent Vascular

Greg Cathcart

Chief Executive Officer
Excellis Health Solutions

Victor Caraballo

Vice President Quality Management
Independence Blue Cross

Gerianne DiPiano

Chief Executive Officer
FemmePharma

Lawana Dumas

Director, Oncology Strategic Alliances
Merck

Lalo Flores

CEO
Century Therapeutics

Shahram Hejazi

Managing Director and CEO
BioAdvance

Calvin Knowlton

Chief Executive Officer
Tabula Rasa

Maria Maccecchini

CEO
Annovis Bio

Matthew Reber

Partner
1315 Capital

Heather Steinman

VP Business Development and Executive Director of Technology Transfer
The Wistar Institute

Zev Sunleaf

Vice President
Office of Technology Transfer, Commercialization & Innovation
Children’s Hospital of Philadelphia

Sponsors

Title Sponsor

Fairmount

Judging Partner

kpmg-pactcapcon-website

Virtual Broadcast Sponsor

BOA-FL-LOGO (1)

Competitive Award Sponsors

Ben Franklin Technology Partners
Troutman Pepper
RSM
SAP
Fox Rothschild
IBX
Baker Tilly
Comcast Business
Cozen O’Connor
EY
Morgan Lewis & Bockius
Cigniti Technologies

Event Sponsors

Tabula Rasa
InstaMed, a JP Morgan Company
New Spring Capital
Boomi
iPipeline
Anexinet
Duane Morris

FINALISTS

Life Sciences & Healthcare Startup

Avisi Technologies
Envara Health
The Discovery Labs

Sponsor: Ben Franklin Technology Partners

Technology Startup

Crossbeam
Grovara
PatientWing

Sponsors: Troutman Pepper

Investment Deal

Passage Bio
TrialScope
Vertex

Sponsors: Baker Tilly and EPAM

Life Sciences & Healthcare Emerging

Antares Pharma
Incyte
Myonex

Sponsor: RSM and SAP

Technology Emerging

Greenphire
Infinite Blue
IntegriChain

Sponsor: EisnerAmper and Fox Rothschild

Life Sciences & Healthcare CEO

Annovis Bio, Maria Maccecchini, PhD
Astarte Medical, Tracy Warren
MOBILion Systems, Melissa Sherman, PhD

Sponsor: EY and Morgan Lewis & Bockius

Technology CEO

iPipeline, Larry Berran
Frontline Education, Mark Gruzin
Odessa, Madhu Natarajan

Sponsors: Cozen O’Connor

Healthcare Innovator

AnaOno
Genomind
NeuroFlow

Sponsor: Independence Blue Cross

Technology Company

AGI, An Ansys Company
Relay Network
Suvoda

Sponsor: Comcast Business